Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention
NCT01487577
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Allogeneic Blood and Marrow Transplantation (BMT)
Graft Versus Host Disease
Interventions
DRUG:
Mycophenolate mofetil
Sponsor
University of Pittsburgh